News – Page 1042 – Endpoints News

Merck’s snapshot of positive data for frontline lung cancer niche triggers a new scramble for quick Keytruda OK

8 years ago

Glass half empty: Achaogen receives split vote from FDA experts on lead antibiotic, shares plunge

8 years ago

FDA’s back-to-back punches against biosims from Celltrion, Novartis leave Roche’s big Rituxan franchise untouched

8 years ago

Third Rock sinks $59M into Casma's 'recycling' tech, with neuro on the mind

8 years ago

Pharma's broken business model — Part 2: Scraping the barrel in drug discovery

8 years ago

Achillion's CEO Milind Deshpande steps down; NeuroVision raises $11.2M for novel Alzheimer's detection tech

8 years ago

Playing the long game in I/O, J&J inks $1.04B deal to buy oncolytic virus platform biotech BeneVir

8 years ago

High cholesterol contender Esperion slips on safety concerns, stock sinks 30%

8 years ago

Iterum tests public market's appetite for anti-infectives in $92M IPO

8 years ago

Chinese investors back Refuge Bio’s $25M B round as it steers gene engineering tech to an IND

8 years ago

Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at ...

8 years ago

Kymriah wins second FDA OK, boosting hope for Novartis' low CAR-T sales

8 years ago

‘Biohacker’ Traywick dead at 28 — known for self-injecting a DIY herpes drug

8 years ago

Pfizer cuts five cancer programs; George Church engages Cellectis' TALEN tech to create virus-resistant human cells

8 years ago

Roche boosts its gene therapy game, expanding partnership with 4D Molecular Therapeutics

8 years ago

Under pressure, Peter Hecht splits Ironwood into two biotechs, spinning out an R&D operation

8 years ago

Biogen tosses in an extra $50M for a bigger slice of the royalties for its PhIII Alzheimer’s drug aducanumab

8 years ago

Sanofi/Regeneron’s one-two punch on PCSK9 price and health data wins a key convert as Express Scripts creates ...

8 years ago

Omega Funds leads $35M Series A to fuel Attenua's cough program, set for proof-of-concept this year

8 years ago

Gilead joins the lineup of big biopharma partners to ally with Verily — this time focused on immunology

8 years ago

IDO rout: Pivotal trials with Bristol-Myers, Merck and AstraZeneca dumped in wake of Incyte's PhIII implosion

8 years ago

Karyopharm stock soars on selinexor's positive PhIIb update, plans for an NDA

8 years ago

Eyeing Eylea's $5B sales, Novartis touts solid 12-week dosing data for its rival RTH258

8 years ago

Two biotechs hunt $175 million in Nasdaq pursuit; Keryx CEO Gregory Madison abruptly resigns; RxCelerate buys ...

8 years ago

First page Previous page 1039 1040 104110421043 1044 1045 Next page Last page